Clinical Trial Update: Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating safety and effectiveness of Propagermanium in diabetic kidney disease patients on irbesartan has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Drugs mentioned

• Irbesartan (irbesartan)
• Propagermanium (propagermanium)

Snippet

Sponsor: Dimerix Bioscience Pty Ltd | Conditions: Diabetic Kidney Disease | Phase 2 | Status: COMPLETED